Addex Therapeutics Ltd. to Report Third Quarter Financial Results and Host Conference Call
Addex Therapeutics Ltd. will announce its Q3 2025 financial results on December 4, 2025. CEO Tim Dyer and Head of Translational Science Mikhail Kalinichev will provide a business update and product pipeline review during a teleconference and webcast at 16:00 CET. Registration is available for the webcast and conference call. The news was generated by Public Technologies using AI and is for informational purposes only.
Addex Therapeutics Ltd. will report its Third Quarter 2025 Financial Results on December 4, 2025. CEO Tim Dyer and Head of Translational Science Mikhail Kalinichev will provide a business update and review of the product pipeline during a teleconference and webcast for investors, analysts, and media at 16:00 CET (15:00 BWT / 10:00 EDT / 07:00 PDT) on that day. Participants can register for the webcast via Registration webcast (Registration%20webcast) and for the conference call via Registration conference media (Registration%20conference%20media). Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Addex Therapeutics Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW1001141825-en) on December 01, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)
